| C03DA01 |
Spironolactone |
Spironolactone Accord |
Film coated tablet |
25 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
75 |
mg |
- |
5.34 |
0.34175 |
3.42 |
25% |
0.85 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-16552/24.08.2018 |
02.10.2018 |
|
|
Активен |
16236 |
| C03DA01 |
Spironolactone |
Spironolactone Accord |
Film coated tablet |
50 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
75 |
mg |
- |
12.01 |
0.34175 |
6.84 |
25% |
1.71 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-16552/24.08.2018 |
02.10.2018 |
|
|
Активен |
16237 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
100 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
14.39 |
0.34175 |
13.67 |
25% |
3.42 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-5071/21.11.2014; НСР-18143/07.03.2019 |
02.04.2019 |
08.09.2012 |
|
Активен |
3370 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
9.48 |
0.34175 |
6.84 |
25% |
1.71 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-5070/21.11.2014; НСР-18142/07.03.2019 |
02.04.2019 |
08.09.2012 |
|
Активен |
3369 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
25 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
5.76 |
0.34175 |
3.42 |
25% |
0.86 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-5069/21.11.2014; НСР-18141/07.03.2019 |
02.04.2019 |
08.09.2012 |
|
Активен |
3368 |
| C03DA01 |
Spironolactone 100% |
C03DA01 Spironolactone 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03DA01 |
Spironolactone |
SPIRONOLACTON ACTAVIS |
Coated tablet |
25 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
4.27 |
- |
0.288 |
2.88 |
100% |
2.88 |
|
I10 |
HCP-8737/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
235 |
| C03DA01 |
Spironolactone |
Spironolactone Accord |
Film coated tablet |
25 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
75 |
mg |
4.5 |
- |
0.288 |
2.88 |
100% |
2.88 |
|
I10 |
HCP-16552/24.08.2018. |
02.08.2019 |
|
|
Активен |
16236 |
| C03DA01 |
Spironolactone |
Spironolactone Accord |
Film coated tablet |
50 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
75 |
mg |
10.12 |
- |
0.288 |
5.76 |
100% |
5.76 |
|
I10 |
HCP-16552/24.08.2018. |
02.08.2019 |
|
|
Активен |
16237 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
100 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
12.12 |
- |
0.288 |
11.52 |
100% |
11.52 |
|
I10 |
HCP-8736/13.04.2016; НСР-18143/07.03.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
3370 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
7.99 |
- |
0.288 |
5.76 |
100% |
5.76 |
|
I10 |
HCP-8736/13.04.2016; НСР-18142/07.03.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
3369 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
25 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
4.85 |
- |
0.288 |
2.88 |
100% |
2.88 |
|
I10 |
HCP-8736/13.04.2016; НСР-18141/07.03.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
3368 |
| C03DA04 |
Eplerenone |
C03DA04 Eplerenone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03DA04 |
Eplerenone |
Carditrust |
Film coated tablet |
50 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
50 |
mg |
- |
30.08 |
0.89767 |
26.93 |
25% |
6.73 |
|
I50.0,I50.1 |
НСР-7498/13.11.2015.; НСР-17689/09.01.2019 предварително изпълнение |
02.09.2019 |
|
|
Активен |
4101 |
| C03DA04 |
Eplerenone |
Carditrust |
Film coated tablet |
25 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
50 |
mg |
- |
26.15 |
0.89767 |
13.47 |
25% |
3.36 |
|
I50.0,I50.1 |
НСР-7498/13.11.2015.; НСР-17702/10.01.2019 |
02.09.2019 |
|
|
Активен |
4100 |
| C03DA04 |
Eplerenone |
Eplerenone Accord |
Film coated tablet |
25 |
mg |
28 |
Accord Healthcare Limited, Обединено Кралство |
50 |
mg |
- |
31.97 |
0.89767 |
12.57 |
25% |
3.14 |
|
I50.0,I50.1 |
НСР-16720/30.08.2018 |
02.09.2019 |
|
|
Активен |
16258 |
| C03DA04 |
Eplerenone |
Eplerenone Accord |
Film coated tablet |
50 |
mg |
28 |
Accord Healthcare Limited, Обединено Кралство |
50 |
mg |
- |
31.97 |
0.89767 |
25.13 |
25% |
6.28 |
|
I50.0,I50.1 |
НСР-16720/30.08.2018 |
02.09.2019 |
|
|
Активен |
16259 |
| C03DA04 |
Eplerenone |
Eplerium |
Film coated tablet |
25 |
mg |
30 |
Stada Arzneimittel AG, Германия |
50 |
mg |
- |
29.1 |
0.89767 |
13.47 |
25% |
3.36 |
|
I50.0,I50.1 |
НСР-11257/22.12.2016 |
02.09.2019 |
|
|
Активен |
15553 |
| C03DA04 |
Eplerenone |
Eplerium |
Film coated tablet |
25 |
mg |
30 |
Stada Arzneimittel AG, Германия |
50 |
mg |
- |
60.08 |
4.00533 |
60.08 |
25% |
15.02 |
|
I50.0,I50.1 |
НСР-2909/05.03.2014; НСР-4777/13.10.2014 |
02.11.2014 |
|
|
Заличен |
2559 |
| C03DA04 |
Eplerenone |
Espiro |
Film coated tablet |
50 |
mg |
30 |
Medana Pharma S.A., Полша |
50 |
mg |
- |
26.93 |
0.89767 |
26.93 |
25% |
6.73 |
|
I50.0,I50.1 |
НСР-19374/02.08.2019 |
02.09.2019 |
|
|
Активен |
16654 |
| C03DA04 |
Eplerenone |
Espiro |
Film coated tablet |
25 |
mg |
30 |
Medana Pharma S.A., Полша |
50 |
mg |
- |
21.25 |
0.89767 |
13.47 |
25% |
3.36 |
|
I50.0,I50.1 |
НСР-19374/02.08.2019 |
02.09.2019 |
|
|
Активен |
16653 |
| C03DA04 |
Eplerenone |
INSPRA |
Film coated tablet |
25 |
mg |
30 |
Pfizer Enterprises SARL, Люксембург |
50 |
mg |
- |
91.25 |
4.00533 |
60.08 |
25% |
15.02 |
|
I50.0,I50.1 |
НСР-3247/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
614 |
| C03DA04 |
Eplerenone |
INSPRA |
Film coated tablet |
25 |
mg |
20 |
Pfizer Enterprises SARL, Люксембург |
50 |
mg |
- |
60.84 |
4.00533 |
40.05 |
25% |
10.01 |
|
I50.0,I50.1 |
НСР-3247/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
613 |
| C03EA01 |
Triamterene/Hydrochlorothiazide |
C03EA01 Triamterene/Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03EA01 |
Triamterene, Hydrochlorothiazide |
DIURETIDIN |
Tablet |
25mg/12.5mg |
mg |
50 |
Актавис EАД, България |
1 |
tabl |
- |
3.82 |
0.0764 |
3.82 |
50% |
1.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6 |
НСР-19009/20.06.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
239 |